Andromeda (ASX:ADN) share price slides 8% despite positive updates

Man in mining or construction uniform sits on the floor with worried look on face

The Andromeda Metals Ltd (ASX: ADN) share price is losing ground today despite a series of updates for its Great White Kaolin project.

The Andromeda share price is down 8% trading at 20.5 cents at the time of writing.

What did Andromeda announce?

Offtake agreements

Earlier this month, the Andromeda share price surged as much as 27% to 27.5 cents following a significant binding offtake agreement for the supply of kaolin product.

The offtake agreement secured a much higher price to what was used in the company’s pre-feasibility study, of A$700/tonne for ceramic grade material.

Additionally, the offtake agreement introduces a second product stream of ultra-bright, high-purity kaolin product, known as “Great White PRM’. The company says this will provide the benefit of product diversification and assist in managing offtake market risk.

Today’s announcement advises that Conrad Partners, a commodity marketing agency, has engaged with high end ceramic users in China to secure additional offtake agreements for Andromeda. Some potential customers have previously signed letters of intent for Great White products. Conrad aims to translate potential interest into binding offtake agreements.

Additionally, Andromeda is in advanced discussion with potential customers located in Europe, the Middle East and other parts of Asia for the Great White refined halloysite-kaolin product.

Definitive feasibility study update

Andromeda advises that its definitive feasibility study (DFS) is “well advanced” but has only focused on the production of Great White CRM for the ceramics market.

The recent binding offtake agreement for Great White PRM for the coatings and polymer market will need to be incorporated into the DFS.

Mining lease application

Andromeda previously lodged a mining please application with the South Australian Department for Energy and Mining (DEM) on 25 February 2021.

The company forecasts the receipt of the mining please approval by mid-2022 in line with DFS and bankable feasibility study (BFS) completion.

Other updates

Andromeda is testing the potential use of its halloysite-kaolin product as a rheology modifier product for the concrete industry. The company has successfully lodged a patent and is currently undertaking additional test work. It said the addition of halloysite-kaolin to concrete could potentially reduce concrete costs, lower carbon footprint and improve performance for concrete suppliers.

The potential concrete application is currently in a testing phase and product marketing has yet to be performed. The company advised that this is unlikely to be included in the DFS.

Andromeda entered into a memorandum of understanding with AEM to use its patented process to make high purity alumina (HPA) using kaolin back in May.

Today’s announcement advised that HPA studies are progressing and samples have been provided to AEM for testing.

The Andromeda share price in 2021

Despite today’s positive list of updates, the Andromeda share price has slipped 6.67% to 21 cents today.

It’s possible today’s sharp fall could be exacerbated by the 1.8% drop in the S&P/ASX 200 Index (ASX: XJO).

The Andromeda share price is down 32% this year, with a year-to-date low of 16 cents.

The post Andromeda (ASX:ADN) share price slides 8% despite positive updates appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

Kerry Sun has no position in any of the stocks mentioned.  The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3vJcWgC

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *